Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 117   

Articles published

ABT 46.05 0.00 (0.00%)
price chart
Abbott Laboratories (ABT) On Momo Momentum Watch Today
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
Related articles »  
Abbott Looking To Electrophysiology For Medical Device Growth (ABT)
Abbott Laboratories recently expanded its medical device business and entered the fast-growing catheter-based electrophysiology market with the acquisition of Topera, Inc. The company also secured the right to buy Advanced Cardiac Therapeutics, ...
Related articles »  
Investors Sell Abbott Laboratories on Strength (ABT)
Abbott Laboratories logo Traders sold shares of Abbott Laboratories (NYSE:ABT) on strength during trading on Friday, AnalystRatingsNetwork.
Investors Sell Shares of Abbott Laboratories on Strength (ABT)  sleekmoney
Abbott Laboratories Hits New 1-Year High at $46.45 (ABT)  Watch List News
Related articles »  
Abbott Laboratories Acquisition
Abbott has had a presence in Russia for nearly 40 years and, in line with its long-term commitment to growing global healthcare markets and capabilities, the company is committed to providing a reliable supply of its healthcare products to Russian ...
Abbott completes purchase of Russian drug company  Chicago Tribune
Abbott, unfazed by political tensions, closes deal for Russia's Veropharm  FiercePharma
Related articles »  
Jon Najarian Sees Unusual Options Activity In Abbott Laboratories
Jon Najarian spoke on CNBC's Fast Money about a high options trading volume in Abbott Laboratories (NYSE: ABT). Options volume was 6 times higher than a daily average in the name and the most active were the December 46 call options.
Related articles »  
Abbott Laboratories acquires Russia's Veropharm
The American pharmaceuticals company Abbott Laboratories has concluded a deal to purchase one of Russia's largest pharmaceutical manufacturers, Veropharm, reports Russia's leading business newspaper, Vedomosti.
Related articles »  
Bullish Options Buyers Are Turning to Abbott Laboratories
NEW YORK -- AbbVie (ABBV) has rallied, and now the bulls are turning to former parent Abbott Laboratories (ABT) . OptionMonster's Heat Seeker tracking program detected the purchase of about 7,500 December 46 calls Tuesday, most of which priced for 37 ...
Related articles »  
Depakote Spina Bifida Lawsuit, Abbott Laboratories
Depakote Spina Bifida Lawsuit, Abbott Laboratories It is not uncommon for women to not know immediately that they are pregnant.
Health Care Equipment and Supplies Equities Scrutiny - Abbott Laboratories ...
Abbott Laboratories' stock lost 2.35%, to close the day at $44.37. The stock recorded a trading volume of 5.48 million shares, above its three months average volume of 5.03 million shares.
Related articles »  
Abbott Laboratories (NYSE:ABT) Commences Tender Offer
[PR Newswire] Abbott Laboratories (NYSE:ABT) announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation (�ALH�), has commenced a tender offer (the �U.